Experts recommend 42-day interval between Sputnik V vaccine doses | Inquirer News

Experts recommend 42-day interval between Sputnik V vaccine doses

By: - Reporter / @DYGalvezINQ
/ 01:09 AM July 07, 2021

MANILA, Philippines — The government’s vaccine experts have recommended increasing the interval between the two doses of Russia’s Sputnik V COVID-19 vaccine from 21 days to 42 days, Food and Drug Administration (FDA) Director-General Eric Domingo said early Wednesday during the taped briefing with President Rodrigo Duterte.

Domingo said the Gamaleya Institute of Russia, the manufacturer of Sputnik V, had sought to increase the interval between vaccine doses of up to 90 days by applying for an amendment of its emergency use authorization (EUA).

Article continues after this advertisement

However, after studying the data, the country’s vaccines experts panel only recommended a maximum interval of 42 days.

FEATURED STORIES

“There’s really no problem. That means that, if the second dose is delayed, but if we give it within 42 days, we have enough reason to believe that the results are all to be very good,” Domingo said, speaking partly in Filipino.

The FDA has yet to issue the amendment of Sputnik V’s EUA.

Article continues after this advertisement

Domingo urged the public to still get their second dose of the vaccine even if they get it a little late.

“It’s still worth it to get the second dose because it will improve and increase your resistance to COVID-19,” he said.

[atm]
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Eric Domingo, FDA

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.